It is a professional services private limited company based in Pune City, Maharashtra, India, established in 2024.
2024 | Pune City, Maharashtra, India | ActiveNucleo-Vir Therapeutics India Private Limited, a active private limited company, was established on 10 September 2024 in Pune City, Maharashtra, India. Engaging in hardware consulting within the professional services sector, it holds CIN: U72100PN2024PTC234244. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹93.00 K .
Its leadership includes Yogesh Bhojraj Ostwal (Director), Sarika Dilip Bamb (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sector 2, Plot 57, Indrayani Nagar, Pune City, Maharashtra, 411039.
U72100PN2024PTC234244
234244
10 September 2024
₹1.00 M
₹93.00 K
Roc Pune
Unlisted
Active
Explore comprehensive insights into Nucleo-Vir Therapeutics India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yogesh Bhojraj Ostwal | Director | 10 Sep 2024 | Current |
| Sarika Dilip Bamb | Director | 10 Sep 2024 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Nucleo-Vir Therapeutics India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Nucleo-Vir Therapeutics India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nucleo-Vir Therapeutics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nucleo-Vir Therapeutics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucleo-Vir Therapeutics India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nucleo-Vir Therapeutics India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Nucleo-Vir Therapeutics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.
The activity Yogesh Bhojraj Ostwal was appointed as a Director was appointed as a Director on 10 Sep 2024 & has been associated with this company since 1 year 3 months . was completed.
Progress on Sarika Dilip Bamb was appointed as a Director was appointed as a Director on 10 Sep 2024 & has been associated with this company since 1 year 3 months . was documented.
The activity Nucleo-Vir Therapeutics India Private Limited was registered on 10 Sep 2024 with Roc Pune & aged 1 year 3 months as per MCA records. was completed.
The CIN of Nucleo-Vir Therapeutics India Private Limited is U72100PN2024PTC234244.
Nucleo-Vir Therapeutics India Private Limited is headquartered at Sector 2, Plot 57, Indrayani Nagar, Pune City, Maharashtra, 411039.
Nucleo-Vir Therapeutics India Private Limited was incorporated on 10 September 2024.
The current directors of Nucleo-Vir Therapeutics India Private Limited are
The primary industry of Nucleo-Vir Therapeutics India Private Limited is Professional Services.
Nucleo-Vir Therapeutics India Private Limited is unlisted.
The authorized capital of Nucleo-Vir Therapeutics India Private Limited is ₹1.00 M, and the paid-up capital is ₹93.00 K .
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX